Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
Public ClinicalTrials.gov record NCT05739435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Patients With Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, open-label extension (OLE) study in patients with plaque psoriasis who have completed their participation in a previous plaque psoriasis study of ESK-001.
Study identification
- NCT ID
- NCT05739435
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 16, 2023
- Primary completion
- Nov 30, 2027
- Completion
- Dec 30, 2027
- Last update posted
- Jul 27, 2026
2023 – 2027
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site # 1029 | Birmingham | Alabama | 35205 | — |
| Investigator Site #1001 | Phoenix | Arizona | 85032 | — |
| Investigator Site # 1023 | Rogers | Arkansas | 72758 | — |
| Investigator Site #1021 | Encinitas | California | 92024 | — |
| Investigator Site #1018 | Los Angeles | California | 90045 | — |
| Investigator Site #1007 | Santa Monica | California | 90404 | — |
| Investigator Site #1002 | Sherman Oaks | California | 91403 | — |
| Investigator site # 1030 | Fort Lauderdale | Florida | 33308 | — |
| Investigator Site #1025 | Hialeah | Florida | 33012 | — |
| Investigator site # 1028 | Miami | Florida | 33175 | — |
| Investigator Site # 1013 | Tampa | Florida | 33614 | — |
| Investigator Site #1035 | Macon | Georgia | 31217 | — |
| Investigator Site #1043 | Sandy Springs | Georgia | 30328 | — |
| Investigator Site #1005 | Rolling Meadows | Illinois | 60008 | — |
| Investigator Site # 1011 | Columbus | Indiana | 47201 | — |
| Investigator Site #1027 | South Bend | Indiana | 46617 | — |
| Investigator SIte#1036 | Overland Park | Kansas | 66210 | — |
| Investigator Site #1017 | Owensboro | Kentucky | 42301 | — |
| Investigator Site #1026 | Rockville | Maryland | 20850 | — |
| Investigator Site #1010 | Clarkston | Michigan | 48346 | — |
| Investigator Site #1031 | New Brighton | Minnesota | 55112 | — |
| Investigator Site #1033 | Norman | Oklahoma | 73071 | — |
| Investigator Site #1019 | Portland | Oregon | 97223 | — |
| Investigator Site #1022 | Philadelphia | Pennsylvania | 19103 | — |
| Investigator Site # 1012 | Rapid City | South Dakota | 57702 | — |
| Investigator Site #1015 | Houston | Texas | 77056 | — |
| Investigator Site # 1006 | San Antonio | Texas | 78213 | — |
| Investigator Site # 1041 | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05739435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05739435 live on ClinicalTrials.gov.